The matter was deliberated in the Subject Expert Committee (SEC- Pulmonary) meeting held on June 6. "The committee recommended that the FDC...

Experts predict that FDC, a pharmaceutical company, may reach Rs 400 in the medium term, provided the stock closes above strong resistance ...

FDC Ltd., incorporated in the year 1940, is a Mid Cap company (having a market cap of Rs 4600.69 Crore) operating in Pharmaceuticals sector.

FDC Ltd. key Products/Revenue Segments include Formulations, Bulk Drugs, Export Incentives, Other Operating Revenue for the year ending 31-...

In order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our ef...

These prescription-only drugs will be available at all retail medical outlets and hospital pharmacies across the country, from November 1, ...

New Delhi, Aug 25 () Drug firm FDC Ltd on Tuesday said it has launched two variants of the COVID-19 drug Favipiravir under the brand names ...

FDC is a smallcap company, operating in pharmaceuticals and health care sector.

"FDC is a 'BUY' call with a target of Rs 272 and a stop loss of Rs 248."

"FDC Ltd is a 'BUY' call with a target of Rs 272 and a stop loss of Rs of 249."

"FDC is a 'BUY' call with a target of Rs 254 and a stop loss of Rs of 240"

"FDC is a 'BUY' call with a target of Rs 157 and a stop loss of Rs 138."

'FDC is a 'BUY' call with a target of Rs 152 and a stop loss of Rs 135.'

FDC Ltd is a ‘BUY’ call with a target of Rs 155 and a stop loss of Rs 134.

FDC surged over 14% to hit a 52-week high of Rs 105.95 on reports that the promoters of the pharma firm, plan to sell their 67% stake in th...

Promoters hold 66.9% stake in the company, which owns popular brands such as the electrolyte substitute ‘Electral’.

Buy FDC in the range of Rs 103-100 with stoploss of Rs 98 for target of Rs 115.